Eukaryotic cells contain numerous membrane compartments, each of which maintains distinct protein and lipid compositions for specific tasks. Trafficking between different membrane compartments occurs via transport vesicles. Transport of proteins along the secretory pathway starts with protein translocation into the endoplasmic reticulum (ER)^1^. Proteins are transported via the intermediate compartment to the Golgi apparatus, which can be subdivided into *cis*-, *medial*-, and *trans*-Golgi compartments. These Golgi compartments are well characterized at the morphological level in mammalian cells ([@B16]). The Golgi compartments of yeast are defined only by the glycosylation and the processing enzymes they contain ([@B18]).

The SNARE hypothesis ([@B63]) proposes that a unique set of proteins on the transport vesicle (v-SNARE) and proteins on the target membrane (t-SNARE) provide specific recognition between both membranes ([@B17]; [@B54]). v- and t-SNAREs have structural similarities. They contain a single COOH-terminal transmembrane domain and regions that are predicted to form coiled coil domains. The yeast proteins Sec22p (Sly2p), Bet1p (Sly12p), Bos1p, and possibly Ykt6p have been identified as v-SNAREs in ER to Golgi transport ([@B39]; [@B44]; [@B62]). Their partner is the t-SNARE Sed5p, which is localized on the first Golgi compartment in yeast ([@B21]). In addition, Sed5p interacts with the v-SNARE Sft1p, which is localized on a more distal Golgi compartment and is therefore involved in retrograde transport ([@B2]). Recently, Ufe1p, a t-SNARE localized in the ER and involved in retrograde transport to the ER, has been identified ([@B31]). Mutations inhibiting retrograde traffic to the ER or to the *cis*-Golgi compartment lead to a very rapid blockage of forward traffic, making it difficult to distinguish by phenotypic analysis whether a protein is involved in anterograde or retrograde transport. The tight coupling of anterograde and retrograde membrane traffic suggests that components needed for forward transport have to be recycled ([@B30]; [@B31]).

The yeast late Golgi compartment, which corresponds to the mammalian TGN, functions as a sorting compartment ([@B50]; [@B41]; [@B64]). Over 50 *VPS* (vacuolar protein sorting) and *PEP* (peptidase deficient) genes have been identified that are involved in the transport of the soluble vacuolar protease carboxypeptidase Y (CPY) from the Golgi apparatus to the vacuole ([@B27]; [@B3]; [@B55]), and none of these genes is essential for cell growth ([@B64]). CPY binds to the CPY sorting receptor, Vps10p, in the late Golgi compartment ([@B36]), and this complex is directed away from the secretory pathway by packaging into transport vesicles that eventually fuse with the prevacuolar or endosomal compartment ([@B52]; [@B68]; [@B49]; [@B64]). Whereas CPY is released and is transported on to the vacuole, the CPY receptor Vps10p recycles to the Golgi apparatus ([@B10]; [@B49]; [@B12]).

Recently, the t-SNARE Pep12p was found to be localized to the yeast prevacuolar compartment ([@B5]). Deletion of the *PEP12* gene leads to the accumulation of small vesicles, suggesting that it is necessary for fusion of Golgi-derived transport vesicles with the prevacuolar compartment.

Here we report the identification of a novel yeast v-SNARE, Vti1p, that interacts with Pep12p and is involved in membrane traffic from the Golgi apparatus to the prevacuolar compartment. *VTI1* was found to be an essential gene, and its essential function is related to the interaction of Vti1p and the *cis*-Golgi t-SNARE Sed5p. Therefore, Vti1p is a v-SNARE that interacts functionally with two t-SNAREs, Pep12p localized to the prevacuolar compartment and Sed5p localized to the *cis*-Golgi compartment.

Materials and Methods
=====================

Materials
---------

Reagents were used from the following sources: enzymes for DNA manipulation from New England Biolabs (Beverly, MA) and Boehringher Mannheim Biochemicals (Indianapolis, IN), secondary antibodies from Promega Biotech. (Madison, WI), Amersham Corp. (Arlington Heights, IL), and Jackson ImmunoResearch Labs (West Grove, PA); ^35^S-Express label and ECL solution from New England Nuclear (Boston, MA); fixed *Staphylococcus aureus* cells (IgG~sorb~) from The Enzyme Center (Malden, MA); Oxalyticase from Enzogenetics (Corvallis, OR); protein G--Sepharose from Pharmacia Fine Chemicals (Uppsala, Sweden); and the plasmid pQE30 and Ni-NTA resin from Qiagen (Hilden, Germany). All other reagents were purchased from Sigma Chemical Co. (St. Louis, MO).

Plasmid manipulations were performed in the *Escherichia coli* strains MC1061 or XL1Blue using standard media. Yeast strains (Table [I](#TI){ref-type="table"}) were grown in rich media (1% yeast extract, 1% peptone, 2% dextrose, YEPD) or standard minimal medium (SD) with appropriate supplements. To induce expression from the *GAL1* promoter, dextrose was replaced by 2% raffinose and 2% galactose.

Plasmids and Strains
--------------------

The plasmids used in this study are listed in Table [II](#TII){ref-type="table"}. pSN206 was constructed by PCR amplifying the *VPS10* tail (codons 1413--1579) with EcoRI--BamHI ends and cloning it into the 2μ-*HIS3* vector pEG202, which makes *LexA* fusion proteins under the control of an ADH promoter ([@B19]). A 1.1-kb fragment starting at the SacI site 150 bp upstream of the *VTI1*-ATG and adding an XhoI site was amplified from genomic DNA and cloned into pBluescript KS^+^. For the disruption construct pSN258 the *VTI1* coding region between the HindIII and NdeI sites was replaced by the *HIS3* gene. pFvM7 consists of *VTI1* (codons 1--194) PCR-amplified with BamHI--SmaI ends in pGex2T ([@B61]). A HindIII site was introduced upstream of the *VTI1* initiation codon and the HindIII--XhoI fragment was cloned together with *GAL1*promoter DNA into pRS314 ([@B60]) to yield pFvM17. pFvM16 is identical to pFvM17 except for the presence of a single HA tag in the BglII site. The MBP--*VTI1*::*HA* fusion construct was derived by PCR amplification of *VTI1* (codons 1--194) with BamHI--HindIII ends and cloning into pMal-p2 ([@B34]). pFvM28, pFvM29, and pFvM32 consist of a 1.8-kb fragment encoding *VTI1* between a SacI and an XhoI site in pRS314, pRS316, or YEp352 ([@B23]). *VTI1* (codons 1--194) was PCR amplified with BamHI--SmaI ends and put into pQE30 to produce pFvM38. pFvM40 was constructed by PCR amplification of *SED5* (codons 1--324; [@B21]) with EcoRI and BamHI ends and subcloning this fragment into pGex2T. pFvM89 contains a PCR-amplified 1.8-kb fragment encoding *SED5* starting 400 bp upstream of the ATG with BamHI and SacI ends in YEp351. PCR mutagenesis was performed as described ([@B38]) using PvuII-digested pFvM28 as template and oligonucleotides annealing to nucleotides 1823--1844 and 2074-- 2053 of pRS314. In the PCR reaction, 3 mM MgCl~2~, 0.25 mM MnCl~2~ and 25 μM dATP, 250 μM dCTP, dGTP, and dTTP, or 25 μM dGTP, 250 μM dATP, dCTP, and dTTP were used. The PCR fragments were cotransformed with XhoI--SacI digested pRS314 into FvMY6 pFvM29. The transformants were pooled, the plasmid pFvM29 removed by plating on 5-fluoroorotic acid (5-FOA) ([@B7]), and colonies screened for CPY secretion at 37°C by colony overlay (Rothman et al., 1986) or for growth at 22° and 37°C. Mutant plasmids were rescued, retransformed, and the plasmid pFvM29 removed to allow isolation of pFvM92 and pFvM93. pFvM103 consists of a PCR-amplified fragment of *SSO2* (codons 1--269; [@B1]) with BamHI and EcoRI ends subcloned into pGex2T. pFvM104 was constructed by subcloning a 2.9-kb EcoRI--SacI fragment from pRB58 ([@B9]) encoding *SUC2* into pRS316.

To delete *VTI1*, a yeast diploid strain (SEY6210 × SEY6211) was transformed with SacI--XbaI-digested pSN258 and selected for His^+^ colonies. A *vti1Δ*::*HIS3* knockout was confirmed by PCR, and the strain was transformed with a *VTI1* covering plasmid. After sporulation, tetrads were dissected and *vti1Δ* cells identified (FvMY6, Table [I](#TI){ref-type="table"}). For hydroxylamine mutagenesis, 250 μg pFvM28 purified on a CsCl-gradient was incubated with 2 ml 0.4 M hydroxylamine in 150 mM KPO~4~, pH 6.0, at 75°C for 60 min ([@B57]). The DNA was cycled through *E. coli* and transformed into FvMY6 containing plasmid pFvM29. The transformants were pooled, the plasmid pFvM29 removed by plating on 5-FOA plates, and colonies screened for CPY secretion at 37°C by colony overlay (Rothman et al., 1986). A mutant plasmid was recovered, retested, and the *vti1-1* DNA subcloned into the integration vector pRS306 ([@B60]). FvMY7 was constructed by integration of this linearized DNA into SEY6211 and looping out the wild-type *VTI1* on 5-FOA plates ([@B7]).

Two Hybrid Screen
-----------------

The strain CTY10-5D carrying the plasmid pSN206 expressing the *LexA-VPS10*(tail) fusion protein was transformed with the libraries pGAD1, pGAD2, and pGAD3 ([@B11]; [@B4]; [@B19]). About 30,000 colonies were screened for expression of the *lacZ* gene. The rescued library plasmid containing the *GAL4* activation domain fused to codons 109--217 of Vti1p, p2H-1, did not interact with the LexA protein alone.

Production of Vti1p and Pep12p Antisera
---------------------------------------

An antiserum was raised in rabbits against a fusion protein containing glutathione--S-transferase and amino acids 1--194 of Vti1p purified from *E. coli.* The antiserum was affinity purified with an Affigel 10 (BioRad Laboratories, Hercules, CA) column with covalently bound maltose-binding protein Vti1p (amino acids 1--194) fusion protein purified from *E. coli.* The Pep12p antiserum was raised in rabbits against a purified fusion protein containing glutathione--S-transferase and amino acids 1--263 of Pep12p.

Immunofluorescence Microscopy
-----------------------------

Indirect immunofluorescence microscopy was performed with SEY6211 cells as previously described ([@B51]). The following antibody combination was used: 1:50 diluted affinity-purified Vti1p antiserum, 1:100 diluted biotin-conjugated goat anti--rabbit IgG (H + L), and 1:100 diluted rhodamine-conjugated streptavidin.

SDS-PAGE and Western Blotting
-----------------------------

Yeast extracts were prepared and the proteins subjected to SDS-PAGE and electroblotting as described ([@B29]; [@B66]). Affinity-purified rabbit antisera were used for the detection of Vti1p, Pep12p, Vps10p ([@B49]), and dipeptidyl aminopeptidase A (DPAP A; [@B53]). Rabbit antiserum was used for PGK and monoclonal antibodies for Vph1p (Molecular Probes Inc., Eugene, OR), Sac1p ([@B37]), and Dpm1p (Molecular Probes Inc.). An incubation with HRP-conjugated secondary antibodies was followed by visualization with ECL reagents.

Subcellular Fractionation
-------------------------

Membrane fractionation by differential centrifugation was performed as described ([@B46]). SEY6211 spheroplasts were lysed, centrifuged at 500 *g* (5 min) to remove debris, at 13,000 *g* (10 min) to yield P13 and S13, and at 200,000 *g* (20 min) to produce P200 and S200.

The S13 fraction was further separated by sucrose gradient centrifugation ([@B5]). The gradient consisted of the following steps: 0.5 ml 60%, 1 ml 37%, 1.5 ml 34%, 2 ml 32%, 2 ml 29%, 1 ml 27%, 1.5 ml 22%, and 1 ml 19% (wt/wt) sucrose in 10 mM Hepes-NaOH, pH 7.6, and was centrifuged for 17 h at 170,000 *g* in an SW41 rotor. 13 fractions were collected from the top. Sucrose density was measured with a refractometer. Fractions were either concentrated by TCA precipitation or directly analyzed by SDS-PAGE and immunoblotting.

Immunoprecipitation of ^35^S-labeled Proteins
---------------------------------------------

The procedure for CPY immunoprecipitation was described earlier ([@B67]). Briefly, log-phase growing yeast cells were labeled for 10 min with ^35^S-Express label (10 μl/0.5 OD of cells) followed by a 30-min chase (chase was initiated by addition of 500 μg/ml methionine and cysteine). Invertase immunoprecipitation and a secondary immunoprecipitation of proteins containing α1,6-mannose linkages were performed as described ([@B18]). Invertase was derepressed by an incubation in minimal medium containing 0.1% glucose, 50 mM KPO~4~, and 1 mg/ml BSA for 45 min at 22°C or 30 min at 22°C plus 15 min at 37°C. Pulse labeling with ^35^S-Express label (10 μl/0.5 OD of cells) was done for 7 min, an aliquot removed (in some experiments), and the remaining sample chased for 30 min. Cells were pelleted, the medium was removed, and the cells were spheroplasted. The spheroplasts were pelleted and lysed giving rise to the intracellular fraction. The supernatant was combined with the medium fraction to yield the extracellular fraction. Immunoprecipitates were analyzed by SDS-PAGE and autoradiography.

Suppressor Screen
-----------------

To identify multicopy suppressors that allow for growth in the absence of Vti1p, the strain FvMY6/pFvM16 (*vti1Δ*/p*CEN-GAL1-VTI1*) was used. FvMY6/pFvM16 cells were transformed with a YEp24 2μ library ([@B9]) and plated on SD-Ura plates, conditions that turn off the expression of *VTI1* (due to the repression of the *GAL1* promoter by dextrose). Colonies that grew were tested for the absence of Vti1p by immunoblot analysis and the inability to grow on 5-FOA plates to determine if the suppression was plasmid linked. Plasmids were recovered, retransformed, and colonies, which lost the pFvM16 plasmid, selected to confirm the suppression. Portions of the inserts were subcloned into YEp351 to determine the minimal DNA fragment needed for suppression.

Native Immunoprecipitation
--------------------------

1 OD~600~nm (∼10^7^ cells) of wild-type yeast cells were spheroplasted, solubilized with 700 μl 0.5% Triton X-100 in PBS, and centrifuged at 12,000 *g* for 10 min. The supernatant fractions were incubated with anti-Vti1p antiserum or pre-immune serum for 2 h at 4°C and then with protein G-sepharose for an additional 2 h at 4°C. The sepharose beads were washed three times for 5 min with 0.5% Triton X-100 in PBS. The proteins bound to the beads were analyzed by SDS-PAGE and immunoblotting with antibodies against Vti1p, Pep12p, Vph1p, and Sac1p. To quantify how much of each protein was immunoprecipitated, the amount of supernatant fraction corresponding to 30 and 10% of the total protein present in the immunoprecipitations were analyzed by SDS-PAGE and immunoblotting.

In vitro Binding Assay
----------------------

Recombinant fusion proteins were purified from *E. coli* extracts. Specifically, bacteria were induced in mid-log phase with 0.5 mM IPTG for 6 h at 30°C to express 6-His--Vti1p (amino acids 1--194). The bacterial pellet was resuspended in 50 mM NaPO~4~, pH 8.0, 300 mM NaCl, frozen, and lysed by sonification. After centrifugation for 10 min with 12,000 *g*, the supernatant was incubated with Ni-NTA resin with mixing for 1 h at 4°C. The resin was loaded in a column, washed with 50 mM NaPO~4~, pH 6.0, 300 mM NaCl, and 10% glycerol, followed by washes with 20 and 100 mM imidazole in the same wash buffer. 6-His--Vti1p was eluted with 500 mM imidazole and dialyzed against PBS. Bacteria were induced with 0.5 mM IPTG for 4 h at 37°C to express GST, GST-Pep12p, GST-Sed5p, and GST-Sso2p. Bacterial pellets were resuspended in PBS, frozen, and lysed by sonification. Debris was removed by centrifugation at 12,000 *g* for 10 min. The supernatant was incubated with glutathione--agarose for 15 min. The beads were washed three times and the amount of bound protein estimated after separation by SDS-PAGE and visualization by Coomassie staining. About 1 μg of these immobilized GST-fusion proteins was incubated with 9 μg of 6-His--Vti1p in 0.5% Triton X-100 in PBS with mixing for 2 h at 4°C. The beads were washed three times with 0.5% Triton X-100 in PBS and the bound protein eluted and analyzed by SDS-PAGE and immunoblotting with anti-Vti1p antibodies.

Electron Microscopy
-------------------

Electron microscopy experiments were performed as described ([@B28]; [@B48]).

To quantify the number of vesicles, 12--20 cells for each condition were photographed. The negatives were scanned, vesicle-like dark structures were counted, and the cytoplasmic area was determined using the NIH Image program. The number of vesicles per unit cytoplasmic area was compared for different conditions. The length of membrane sheets that were not adjacent to the cell wall or around the nucleus was measured using the NIH Image program and divided by the cytoplasmic area as a measure for ER accumulation.

Results
=======

Identification of VTI1
----------------------

We were interested in identifying proteins that are involved in trafficking of the CPY sorting receptor Vps10p ([@B36]). Since the cytosolic tail of Vps10p directs its recycling ([@B10]; [@B12]), this portion of the protein was fused to the LexA DNA-binding domain to create a "bait" protein to screen for interacting proteins in the yeast two-hybrid system ([@B8]; [@B11]). An activating plasmid containing the *VTI1* gene (Vps ten interacting) was isolated and the insert sequenced. The sequence matched an open reading frame upstream of *CIK1* ([@B45]), which was also sequenced by the Genome Sequencing Project on chromosome XIII and designated open reading frame YMR197c. *VTI1* is predicted to encode a protein of 217 amino acids with a COOH-terminal transmembrane domain (Fig. [1](#F1){ref-type="fig"}).

The regions adjacent to the transmembrane domain are predicted to fold into an amphipathic α-helical coiled coil domain. These structural elements are characteristic of SNARE proteins ([@B17]; [@B54]). In pairwise sequence comparisons with SNARE proteins, Vti1p shares the highest sequence similarity with synaptobrevin (VAMP; 28% amino acid identity) and with Sft1p (32% amino acid identity), which are much smaller proteins. Sft1p is a yeast v-SNARE involved in retrograde transport to the *cis*-Golgi compartment ([@B2]), and synaptobrevin is a v-SNARE found on synaptic vesicles. Domains close to the NH~2~ terminus of Vti1p (amino acids 39--63) and of synaptobrevin (amino acids 29--56) are predicted to adopt the same structure as viral fusion peptides with charged amino acids on one side of the α-helix and bulky hydrophobic amino acids on the other. The presence of a domain of this sort close to the NH~2~ terminus is characteristic for v-SNAREs ([@B13]; [@B69]; [@B24]). In general, members of the v-SNARE family share common structural elements but exhibit low sequence identities in pairwise combinations (18--35% amino acid identities), and Vti1p fits this pattern.

t-SNAREs display significant amino acid sequence identity in the coiled coil domain adjacent to the transmembrane domain, and these regions of identity do not extend to v-SNAREs such as Vti1p. Most t-SNAREs contain nine invariant amino acid residues in this region ([@B47]; [@B31]). The coiled coil domain in Vti1p does not share sequence identity with this coiled coil domain in different t-SNAREs (8% compared to Pep12p, 13% compared to Sed5p, and 17% compared to syntaxin3 and syntaxin5). Only two of the invariant nine amino acid residues are present in Vti1p. Therefore, by all of the above criteria, Vti1p belongs to the v-SNARE family of proteins.

Vti1p Localizes to Golgi and Prevacuolar Membranes
--------------------------------------------------

A rabbit antiserum was generated against Vti1p. Anti-Vti1p antibodies identified a single 27-kD band in protein extracts from wild-type yeast cells analyzed by SDS-PAGE and immunoblotting. This band was more intense in a strain carrying a high copy *VTI1* plasmid and absent in *vti1Δ* mutant cells (data not shown). Vti1p was immunolocalized by indirect immunofluorescence in wild-type cells. Vti1p antibodies labeled numerous punctate structures throughout the cytosol (Fig. [2](#F2){ref-type="fig"} *a*), some of which were adjacent to the vacuole, but vacuolar and ER membranes were not stained.

Differential centrifugation of wild-type yeast lysates followed by SDS-PAGE and immunoblot analysis (Fig. [2](#F2){ref-type="fig"} *b*) revealed that Vti1p was predominantly localized in the 200,000 *g* membrane pellet (P200), which contained small vesicles and Golgi membranes, as defined by the enrichment of the proteins DPAP A and Vps10p ([@B46]; [@B53]; [@B36]). Lower amounts of Vti1p were present in the 13,000 *g* pellet (P13), which included vacuolar (Vph1p \[[@B35]\]), ER (Dpm1p \[[@B43]\]), and mitochondrial membranes. The prevacuolar t-SNARE Pep12p was most abundant in the P200 fraction with lower amounts in the P13 fraction, consistent with previous results ([@B5]). As expected, the cytosolic protein PGK fractionated with the S200 soluble protein fraction.

To study the localization of Vti1p in more detail, the 13,000 *g* supernatant (S13) was separated on a 19--37% sucrose density equilibrium gradient ([@B5]). Fractions were collected from the top and analyzed by SDS-PAGE and immunoblot analysis (Fig. [2](#F2){ref-type="fig"} *c*). Vti1p was found at two different buoyant densities: in fractions 6--8 (at 29.5% sucrose) and in fraction 12 (36.4% sucrose). As observed previously ([@B5]), Golgi membranes (as indicated by the presence of DPAP A) migrated close to the bottom of the gradient and cofractionated with the higher density Vti1p peak. By contrast, Pep12p was found in a single peak together with the lower density Vti1p peak. These data indicate that a smaller portion of Vti1p is localized in the Golgi apparatus, whereas the majority is colocalized with Pep12p in the prevacuolar compartment.

VTI1 Is an Essential Gene Required for CPY Sorting
--------------------------------------------------

The *VTI1* gene was disrupted in yeast to determine the functional role of Vti1p. One of the copies of *VTI1* in a diploid strain (SEY6210 × SEY6211) was disrupted by replacement with the *HIS3* gene (*vti1Δ::HIS3*). Tetrad dissections did not yield viable His^+^ spores, revealing that *VTI1* is an essential gene. His^+^ spores derived from tetrad dissection of FvMY4 after transformation with a *VTI1* plasmid were only viable in the presence of the *VTI1*-containing plasmid. *vti1Δ::HIS3* cells carrying the *VTI1--URA3* plasmid could not grow on 5-FOA because plasmid loss was lethal, confirming that *VTI1* is an essential gene. By contrast, none of the *VPS* or *PEP* genes are essential for haploid yeast cell growth ([@B64]).

The phenotypic consequences of the loss of Vti1p were investigated by placing *VTI1* expression under the control of the *GAL1* promoter. *vti1Δ* cells carrying the *GAL1-- VTI1* plasmid were maintained on galactose-containing medium. Approximately 20 h after shifting these cells to glucose-containing medium (about six cell divisions) the cells stopped dividing (Fig. [3](#F3){ref-type="fig"} *a*). Immunoblot analysis revealed that *VTI1* expression under control of the *GAL1* promoter was ∼10-fold higher in the presence of galactose than expression from the *VTI1* promoter. Wild-type levels of Vti1p were reached ∼12 h after shift to glucose medium (data not shown).

To determine if sorting of the soluble vacuolar hydrolase CPY was affected by lowered Vti1p levels, the fate of newly synthesized CPY was monitored in *GAL1--VTI1* cells grown on galactose medium or after shift to glucose medium for different periods of time (Fig. [3](#F3){ref-type="fig"} *b*). Pulse-- chase immunoprecipitations of CPY in *GAL1--VTI1* cells grown on galactose medium or grown on glucose medium for 12 h revealed that CPY was found only in the mature, vacuolar form in the intracellular fraction, reflecting correct sorting and delivery of CPY to the vacuole. After growth on glucose medium for 16 h, hardly any newly synthesized CPY reached the vacuole. Instead, the Golgi-modified precursor form of CPY (p2CPY \[[@B65]\]) was secreted. These data indicate that Vti1p is necessary for sorting of the soluble vacuolar hydrolase CPY. This missorting of CPY occurred before the growth defect became apparent, suggesting that it was not an indirect effect. After the *GAL1--VTI1* cells had grown on glucose medium for 20 to 24 h, the ER and early-Golgi form of CPY (p1CPY \[[@B65]\]) was found to accumulate. These data imply that transport through the Golgi apparatus was slowed or blocked upon severe depletion of Vti1p. However, it remains unclear whether p1CPY accumulation was caused directly by Vti1p depletion or an indirect effect due to the severe growth defect.

vti1 Mutants Are Defective in Two Vesicle Traffic Steps
-------------------------------------------------------

The genes identified as being required for vacuolar protein sorting (*VPS*) are all nonessential in yeast, yet *VTI1* function is required for CPY sorting, and the gene is essential. This suggests that *VTI1* has a second function in addition to vacuolar protein sorting. Temperature-sensitive *vti1* mutants were generated to elucidate the role of Vti1p in Golgi to vacuolar traffic and the essential function for this protein. Using shuttle mutagenesis with hydroxylamine-treated *VTI1* on a *CEN*-based plasmid, a mutant was identified (*vti1-1*) that secreted CPY at 37°C yet grew with nearly a wild-type doubling time at this temperature. The *vti1-1* mutation was integrated into the genome for further analysis. Additional *vti1* alleles (*vti1-2* and *vti1-11*) were generated by PCR mutagenesis. *vti1-11* grew normally at 20°C but grew very slowly at 37°C. The doubling time of *vti1-11* at 37°C was about 10 h compared to 2.5 h for wild-type yeast cells. The *vti1-2* mutant cells had a slight growth defect at 37°C.

The effects of the *vti1* mutations on CPY sorting were studied by CPY immunoprecipitations after pulse--chase labeling. CPY was correctly transported to the vacuole at 22°C in the *vti1-1* mutant (Fig. [4](#F4){ref-type="fig"}, *top row*). If ^35^S label was added immediately upon shift to 36°C, very little CPY reached the vacuole, and instead the Golgi-modified p2CPY was either secreted or accumulated intracellularly. The amount of p1CPY detected was small and varied somewhat between experiments. In cells that were labeled at 22°C after a preincubation at 36°C (30 min), the majority of CPY reached the vacuole (as evidenced by the presence of mature CPY; mCPY), indicating that the *vti1-1* temperature-sensitive mutation is rapidly reversible. This extremely fast onset of the CPY sorting defect and fast recovery demonstrate that Vti1p is directly involved in CPY transport from the Golgi apparatus to the vacuole. The mutant *vti1-2* also exhibited a fast onset of CPY secretion upon shift to 36°C (Fig. [4](#F4){ref-type="fig"}, *middle row*), however, the recovery was somewhat slower. The extent of CPY secretion was greater in *vti1-2* mutant cells than in *vti1-1* mutant cells upon shift to 36°C; some p2CPY accumulated intracellularly but p1CPY did not.

In the *vti1-11* mutant, which was temperature sensitive for growth, CPY reached the vacuole and was processed normally at 22°C (Fig. [4](#F4){ref-type="fig"}, *bottom row*). p1CPY was the predominant form of the protein found when *vti1-11* cells were labeled at the restrictive temperature (36°C). Lower amounts of intracellular and secreted p2CPY were also present, but mature CPY was not. After return to the permissive temperature, CPY sorting to the vacuole recovered quickly in *vti1-11* cells, indicating that the *vti1-11* temperature-sensitive mutation is rapidly reversible. These experiments indicate that in the *vti1-11* cells, CPY accumulated either in the ER or in the *cis*-Golgi compartment (as p1CPY) with a rapid onset upon shift to the restrictive temperature. CPY that reached the *trans*-Golgi compartment was not targeted to the vacuole but instead secreted, suggesting that Golgi to vacuole traffic is also defective in *vti1-11* mutant cells.

To further characterize these mutants, trafficking of the secretory protein invertase was studied (Fig. [5](#F5){ref-type="fig"}). In wild-type yeast cells the core glycosylated ER form of invertase seen before the chase period received outer chain glycosylation and was secreted during the chase at 22° (Fig. [5](#F5){ref-type="fig"} *a*, lanes *1--4*) and at 36°C (lanes *5--9*). As expected, *sec18-1* cells, which are defective in ER to Golgi vesicle traffic ([@B15]), accumulated the core glycosylated ER form of invertase at the restrictive temperature (Fig. [5](#F5){ref-type="fig"} *c*, lanes *1--4*). Invertase glycosylation and transport were normal in all of the *vti1* mutants at 22°C. In the *vti1-11* mutant labeled at 36°C, the ER form and a slightly larger form of invertase accumulated intracellularly (Fig. [5](#F5){ref-type="fig"} *a*, lane *15*). Invertase molecules that were secreted by *vti1-11* mutant cells were severely underglycosylated (Fig. [5](#F5){ref-type="fig"} *a*, lane *16*). By contrast, nearly all invertase was secreted by *vti1-1* cells, but it was somewhat underglycosylated at the restrictive temperature (Fig [5](#F5){ref-type="fig"} *b*, lanes *15* and *16*). Glycosylation and secretion of invertase were nearly normal in the *vti1-2* cells at the nonpermissive temperature (Fig. [5](#F5){ref-type="fig"} *b*, lanes *7* and *8*), indicating that in the *vti1-2* mutant only transport from the late-Golgi compartment to the vacuole was blocked.

Glycosylation occurs in a characteristic order in *Saccharomyces cerevisiae* because glycosylation enzymes are localized in separate Golgi subcompartments ([@B18]; [@B20]). In the first Golgi compartment, one to four α1-6 mannose residues are added to Asn-linked carbohydrate chains. Further α1-6 mannose outer chain elongation follows in the next compartment. The next modification is addition of α1-2 and α1-3 mannose. Secondary immunoprecipitation with antiserum against α1,6-mannose linkages was used to determine whether the internal invertase that accumulated in *vti1* mutant cells had received this modification after chase at the restrictive temperature. The lower molecular weight fraction of invertase that accumulated in *vti1-11* cells (Fig. [5](#F5){ref-type="fig"} *d*, lane *1*) had not received α1,6-linked mannose and was similar to the core glycosylated, ER-localized invertase found in *sec18-1* mutants (Fig. [5](#F5){ref-type="fig"} *d*, lanes *3* and *4*), which could not be immunoprecipitated with antiserum against α1-6 mannose linkages. The slightly larger molecular weight fraction of invertase in the *vti1-11* cells (Fig. [5](#F5){ref-type="fig"} *d*, lane *2*) contained α1,6-linked mannose and had therefore reached the *cis*-Golgi compartment. These data indicate that ER to Golgi membrane traffic is drastically slowed in *vti1-11* mutant cells shifted to the nonpermissive temperature. Secretion of under-glycosylated invertase still occurred slowly, suggesting that the *vti1-11* allele was "leaky" and that the Golgi apparatus had lost the ability to glycosylate invertase normally.

The behavior of *vti1-11* mutant cells is reminiscent of *sec22Δ*/*sly2Δ* cells at nonpermissive temperature ([@B44]) and *ypt1-1* mutant cells ([@B59]). Sec22p/ Sly2p is a v-SNARE necessary for ER to *cis*-Golgi membrane traffic. Ypt1p, a rab-related small GTPase, is involved in ER to *cis*-Golgi and *cis*- to *medial*-Golgi vesicle fusion ([@B25]). As with *vti1-11* cells, *ypt1-1* mutant cells slowly secrete underglycosylated invertase ([@B59]). These data indicate that Vti1p is required both for membrane traffic at the *cis*-Golgi compartment and for sorting CPY from the Golgi apparatus to the vacuole.

Electron microscopy was used to investigate whether *vti1* mutant cells accumulated membrane organelles. Wild-type, *vti1-1*, and *vti1-11* cells were grown at 22°C, incubated for 1 h at 37°C, and prepared for electron microscopy (Fig. [6](#F6){ref-type="fig"}). The *vti1-1* and *vti1-11* cells contained about three times the number of small vesicles relative to isogenic wild-type cells. In addition, *vti1-11* cells accumulated more ER membranes than wild-type cells, but *vti1-11* cells contained similar amounts of ER membranes at both 22° and 37°C. The accumulation of vesicles in *vti1-1* and *vti1-11* mutant cells is consistent with a proposed role for Vti1p as a v-SNARE in vesicle docking and membrane fusion.

SED5 Overexpression Suppresses vti1Δ Lethality
----------------------------------------------

To elucidate further the essential function of *VTI1*, we screened for multicopy suppressors that allow yeast cells to grow in the absence of Vti1p. A *vti1Δ* strain harboring the *GAL1--VTI1* plasmid was transformed with a multicopy yeast library ([@B9]) and transformants plated on glucose plates to switch off expression of *VTI1.* Yeast transformants capable of forming a colony on glucose media were tested for the absence of Vti1p by immunoblotting and for the inability to lose the multicopy plasmid to confirm that the suppression was linked to the library plasmid. In addition, the library plasmid was recovered, retransformed, and a *vti1Δ* strain isolated that did not contain the *GAL1--VTI1* plasmid. A plasmid containing a 7.7-kb DNA insert was identified that supported growth in the absence of Vti1p. The minimal complementing fragment (2.7 kb) contained the gene *SED5*, which encodes a t-SNARE involved in anterograde transport from the ER to the early-Golgi compartment as well as retrograde transport from the *medial*- to the early-Golgi compartment ([@B21]; [@B2]). To confirm that *SED5* was a *vti1Δ* suppressor, a fragment encoding Sed5p plus 400 bp 5′ and 400 bp 3′ of the coding region was amplified by PCR and cloned into a multicopy yeast vector. The 2μ-*SED5* plasmid (pFvM89) was transformed into *vti1Δ* cells that carried a *CEN*-based *URA3--VTI1* plasmid. The *URA3--VTI1* plasmid was removed by plating cells on 5-FOA plates, resulting in *vti1Δ* cells containing the 2μ-*SED5* plasmid that were able to grow with a doubling time of 5 h compared to a doubling time of 3 h for *VTI1* wild-type yeast cells. Immunoblot analysis demonstrated that these cells were not expressing Vti1p.

To investigate whether overexpression of the prevacuolar t-SNARE Pep12p could suppress lethality due to the *vti1Δ* mutation, *vti1Δ* cells carrying the *URA3--VTI1* plasmid were transformed with a multicopy *PEP12* plasmid (2μ-*PEP12*). Overexpression of Pep12p was confirmed by Western blot analysis (data not shown). *vti1Δ* cells carrying the 2μ-*PEP12* and *URA3-VTI1* plasmids failed to grow on 5-FOA, indicating that these cells could not lose the *VTI1* plasmid. It was also determined whether *vti1Δ* cells carrying the 2μ-*PEP12* or the 2μ-*SED5* plasmid and expressing *VTI1* from the *GAL1* promoter could grow when Vti1p expression was repressed on glucose medium. Whereas the 2μ-*SED5* plasmid could support growth of *vti1Δ* cells after shut off of *GAL1--VTI1* expression (Glc medium), the multicopy *PEP12* plasmid could not (Fig. [7](#F7){ref-type="fig"}). These results demonstrate that *VTI1* and *SED5* interact genetically, providing further evidence that the essential function of *VTI1* involves membrane traffic in to or out of the early-Golgi compartment.

Overexpression of Pep12p or Sed5p Restores CPY Transport
--------------------------------------------------------

The function of Vti1p was investigated further by monitoring the effects of overexpression of the t-SNAREs Pep12p and Sed5p on trafficking of CPY in the various *vti1-ts* mutants (Fig. [8](#F8){ref-type="fig"}). Whereas *vti1-1* mutant cells secreted 44% of CPY at 36°C (average of four experiments; Fig. [8](#F8){ref-type="fig"} *a*, lane *2*) and sorted only 6% of CPY to the vacuole, overexpression of Pep12p led to a significant decrease in CPY secretion (26%, lane *6*) and an increase in intracellular mature CPY (30%, lane *5*). This dramatic increase in intracellular CPY (6--30%) due to Pep12p overexpression reflects a highly significant suppression of the CPY sorting defect in *vti1-1* mutant cells. This suppression was allele specific because overexpression of Pep12p did not suppress the sorting defect observed in *vti1-2* mutant cells (data not shown). By contrast, overexpression of Sed5p did not have an effect on CPY sorting in *vti1-1* cells (Fig. [8](#F8){ref-type="fig"} *a*, lanes *3* and *4*). These data indicate that in *vti1-1* mutant cells, which are defective in transport of CPY from the late-Golgi apparatus to the vacuole, the overexpression of the prevacuolar-localized t-SNARE Pep12p restored the ability of vesicles to dock and fuse with the prevacuolar compartment.

We also investigated whether overexpression of either Pep12p or Sed5p could suppress the membrane traffic defect at the *cis*-Golgi compartment in *vti1-11* mutant cells. Overexpression of Sed5p in the *vti1-11* strain reduced the amount of p1CPY that accumulated at restrictive temperature and increased the amount of secreted p2CPY (Fig. [8](#F8){ref-type="fig"} *b*, lanes *3* and *4*). Whereas 56% of the total CPY was found as p1CPY and 21% was secreted as p2CPY in *vti1-11* mutant cells at the restrictive temperature (Fig. [8](#F8){ref-type="fig"} *b*, lanes *1* and *2*), overexpression of Sed5p led to a decrease in p1CPY accumulation to 28% and an increase in secreted p2CPY to 44% (average of two experiments). By contrast, overexpression of Pep12p in *vti1-11* cells did not suppress the CPY missorting defect or the accumulation of p1CPY (Fig. [8](#F8){ref-type="fig"} *b*, lanes *5* and *6*). These results indicate that in *vti1-11* mutant cells, which are blocked in traffic to the early-Golgi compartment, overexpression of the early-Golgi t-SNARE Sed5p (but not Pep12p) promoted CPY transport from the ER to the Golgi compartment but had no effect on transport of CPY from the late-Golgi compartment to the vacuole.

Vti1p Interacts with the Cytosolic Domains of Pep12p and Sed5p
--------------------------------------------------------------

To determine whether Vti1p and Pep12p interact directly, Vti1p was immunoprecipitated from yeast lysates solubilized with 0.5% Triton X-100. The native immunoprecipitation samples were analyzed by SDS-PAGE and immunoblotted for Vti1p, Pep12p, and two control membrane proteins. Approximately 10% of the total Pep12p was coprecipitated with Vti1p (Fig. [9](#F9){ref-type="fig"} *a*). Importantly, preimmune serum did not precipitate Pep12p, and anti-Vti1p antibodies did not coprecipitate two other membrane proteins, Vph1p (a vacuolar membrane protein \[[@B35]\]) or Sac1p (ER and Golgi membrane protein \[[@B37]\]). These data indicate that Vti1p and Pep12p interact specifically.

Because Vti1p was identified in a two-hybrid screen with the cytosolic domain of Vps10p as "bait," we investigated whether Vti1p and Vps10p interacted physically. Only very low levels of the CPY receptor, Vps10p (\<2% of the total Vps10p), coprecipitated with Vti1p under native immunoprecipitation conditions (data not shown), and additional experiments suggest that this effect may be nonspecific. Specific binding between Vps10p and Vti1p could not be detected using either chemical crosslinking followed by immunoprecipitation or in vitro binding assays with the soluble cytosolic domains. This may reflect a low degree of colocalization between Vps10p and Vti1p or that these proteins interact only transiently. Whether Vps10p and Vti1p interact functionally remains unclear.

An in vitro binding assay was used to study further the interaction of Vti1p with different yeast t-SNAREs. The soluble cytosolic domain of Vti1p was expressed in *E. coli* and purified as a 6-His--fusion protein. GST-fusion proteins with the soluble domains of the yeast t-SNAREs Pep12p (prevacuolar compartment \[[@B5]\]), Sed5p (*cis*-Golgi compartment \[[@B21]\]), and Sso2p (plasma membrane \[[@B1]\]) were expressed in *E. coli* and purified. Each of the GST-fusion proteins immobilized on glutathione agarose was incubated with a constant amount of the purified 6-His-- Vti1p (see Materials and Methods). The pellets were washed and the bound protein eluted, separated by SDS-PAGE, and then analyzed by immunoblotting for bound Vti1p (Fig. [9](#F9){ref-type="fig"} *b*). High levels of Vti1p bound to the GST--Sed5p fusion. Consistent with the coimmunoprecipitation data, Vti1p also bound to GST--Pep12p. By contrast, Vti1p did not bind to GST--Sso2p or to GST alone. These data indicate that Vti1p interacts specifically with a prevacuolar t-SNARE (Pep12p) and a *cis*-Golgi t-SNARE (Sed5p) but not with a t-SNARE (Sso2p) involved in a pathway (secretory vesicle fusion with the plasma membrane) that is unaffected in *vti1* mutant cells.

Discussion
==========

We have identified a new v-SNARE, Vti1p, that functions in membrane traffic to the yeast vacuole. More importantly, these studies have revealed that a single v-SNARE can function in two separate vesicle trafficking steps. The yeast v-SNARE Vti1p was found to interact with two t-SNAREs, one found on the *cis*-Golgi compartment (Sed5p) and the second on the prevacuolar compartment (Pep12p). The specificity of the v- and t-SNAREs for each other must necessarily require the intimate involvement of additional proteins (e.g., Rab/Ypt proteins, Sec1 protein family members, and/or other proteins) so that a single v-SNARE can control the fusion of two different classes of vesicles.

Role of Vti1p in Golgi to Prevacuole Membrane Traffic
-----------------------------------------------------

Upon depletion of Vti1p, yeast cells secreted the vacuolar hydrolase CPY, a phenotype characteristic of vacuolar protein sorting (*vps*) mutants ([@B64]). This result was confirmed by the isolation of the temperature-sensitive *vti1* mutants, *vti1-1* and *vti1-2*, that displayed CPY secretion with rapid onset upon shift to restrictive temperature as well as rapid recovery upon return to permissive temperature. Therefore, Vti1p is directly involved in transport of CPY from the late Golgi compartment to the vacuole.

Recently, Pep12p was identified as a t-SNARE involved in sorting CPY, and this protein was localized to the prevacuolar compartment, suggesting that it acts in docking and fusion of Golgi-derived transport vesicles ([@B5]). Therefore, we tested whether Vti1p is the v-SNARE partner of Pep12p. Overexpression of Pep12p in the *vti1-1* strain suppressed the CPY sorting defect significantly at the restrictive temperature. This suppression did not represent a general bypass of the Vti1p-dependent step because it was allele specific. Native immunoprecipitation and an in vitro binding assay demonstrated physical interaction between Vti1p and Pep12p. In addition, Vti1p localized both to the Golgi apparatus and the prevacuolar compartment, consistent with a role in Golgi to prevacuolar traffic. *vti1-1* cells were found to accumulate small vesicles at the restrictive temperature. Taken together, these data indicate that Vti1p--Pep12p SNARE complex formation is required for consumption of Golgi-derived transport vesicles at the prevacuolar compartment (Fig. [10](#F10){ref-type="fig"}).

Role of Vti1p in Early-Golgi Membrane Traffic
---------------------------------------------

In contrast to all *VPS* genes ([@B64]), *VTI1* is an essential yeast gene, suggesting that it may have a second function in addition to regulating membrane traffic to the vacuole. The mutant *vti1-11* grew very slowly and rapidly accumulated the ER and early-Golgi form of proCPY (p1CPY) upon shift to the restrictive temperature. CPY sorting recovered quickly after return to the permissive temperature. The core glycosylated ER form and the slightly larger α1,6-linked mannose-containing, *cis*-Golgi form of the secreted protein invertase accumulated intracellularly in the *vti1-11* strain at the restrictive temperature. The fact that some invertase had received the initial α1,6-mannose modification indicates that glycosylation in the *cis*-Golgi compartment is normal. The remainder of the invertase was secreted but was severely underglycosylated. This suggests that invertase failed to receive α1,6-mannose chain elongation, which occurs in the *medial*-Golgi compartment. These defects in invertase secretion and processing are reminiscent of the phenotype of the *ypt1-1* mutant ([@B59]). Ypt1p acts in ER to early-Golgi and in early- to *medial*-Golgi vesicle fusion steps ([@B25]). An accumulation of ER core glycosylated invertase and secretion of partially glycosylated invertase was also observed at the nonpermissive temperature in *sly2/sec22Δ* cells ([@B44]). Sec22p/Sly2p is a v-SNARE involved in vesicle transport from the ER to the early-Golgi compartment. These similarities indicate that trafficking into and/or out of the early-Golgi compartment is blocked or severely slowed down in *vti1-11* mutant cells. The mechanisms causing underglycosylation are unclear. Possible explanations could be indirect effects due to failure to retrieve glycosylation enzymes from the TGN or the prevacuolar compartment, or that conditions in the Golgi lumen are unfavorable for the glycosylation enzymes.

The cytosolic domains of Vti1p and of the early-Golgi t-SNARE Sed5p ([@B21]) were found to interact in an in vitro binding assay. The binding data suggest that Vti1p and Sed5p form a SNARE complex required for membrane transport to the *cis*-Golgi compartment (Fig. [10](#F10){ref-type="fig"}). Genetic analysis revealed a strong interaction between the *VTI1* and the *SED5* genes. Strains in which *VTI1* was deleted were able to grow if Sed5p was overexpressed, indicating that *SED5* is a bypass suppressor of lethality due to the *vti1Δ* mutation. In addition, overexpression of Sed5p in *vti1-11* cells suppressed the accumulation of p1CPY, indicating that excess Sed5p overcame the *cis*-Golgi transport block in these cells. However, while Sed5p overexpression could suppress the *cis*-Golgi transport block of *vti1-11* cells, Sed5p overexpression had no effect on the vacuolar protein sorting defect of any *vti1* mutant (*vti1-1*, *vti1-11*, or *vti1Δ*/2μ-*SED5*). These data are not inconsistent with the Vti1p--Sed5p in vitro binding data. *SED5* may be able to act as a bypass suppressor of a *VTI1* deletion if a second protein on the transport vesicles interacts with Vti1p and facilitates the formation of the Sed5p--Vti1p SNARE-complex. This protein could allow a less efficient fusion of transport vesicles if high levels of Sed5p are present on the target membrane. In fact, it has been demonstrated that a complex of the v-SNAREs Bos1p and Sec22p in ER-derived transport vesicles is necessary for efficient formation of a SNARE complex with Sed5p in ER to *cis*-Golgi transport ([@B32]; [@B26]).

It is important to note that a block in ER to Golgi traffic does not necessarily implicate Vti1p in this exact trafficking step. It was reported recently that a block in retrograde traffic from the Golgi apparatus to the ER leads to a rapid block in anterograde traffic from the ER to the Golgi apparatus ([@B30]; [@B31]). In fact there were no differences in the lag before p1CPY accumulated in cells conditionally defective for proteins involved in anterograde traffic (*sec18*, *sec12*) or retrograde traffic (*ufe1*, *sec20*, *sec21*). It is unlikely that Vti1p acts together with the v-SNAREs Sec22p/Sly2p, Bet1p/Sly12p, and Bos1p in ER to *cis*-Golgi traffic, because Sec22p, Bet1p, and Bos1p were localized predominantly to the ER by a combination of immunofluorescence and subcellular fractionation ([@B40]; [@B26]), whereas Vti1p was not detected in the ER.

We propose that Vti1p is involved in retrograde traffic to the *cis*-Golgi compartment in yeast. Whereas anterograde Golgi traffic is studied extensively, not much is known about retrograde transport. Because v-SNAREs bud with transport vesicles from the donor compartment and are incorporated into the target membrane there has to be a mechanism by which v-SNAREs and other components of the transport machinery recycle to the donor compartment. Recently, evidence for retrograde traffic from the *medial*- to the *cis*-Golgi compartment in yeast was reported ([@B2]). It was also reported that the *cis*-Golgi enzyme Och1p rapidly reaches the TGN and returns to the *cis*-Golgi compartment by retrograde transport ([@B22]). The localization of the *medial*-Golgi protein Emp47p involves retrograde transport to the ER ([@B58]). Recycling of late-Golgi proteins from the prevacuolar compartment back to the Golgi apparatus has also been demonstrated ([@B10]; [@B49]; [@B12]; [@B42]), but it is unclear which Golgi stack serves as the acceptor membrane. In all examples it is also not clear whether retrograde traffic moves back from compartment to compartment, mirroring anterograde flow, or whether retrograde transport vesicles from different compartments have a common target, e.g., the ER or the *cis*-Golgi compartment ([@B56]).

Vti1p is probably not involved in retrograde traffic from the *medial*- to the early-Golgi compartment together with the v-SNARE Sft1p, because the phenotypes resulting from *vti1* and *sft1* mutations are different. At the restrictive temperature, *sft1-ts* mutants accumulated large amounts of Golgi membranes and the early-Golgi but not the ER form of invertase ([@B2]). An attractive possibility is that Vti1p is involved in retrograde vesicle traffic from the prevacuolar compartment back to the *cis*-Golgi compartment. Alternatively, Vti1p could control retrograde traffic from the late-Golgi to the *cis*-Golgi compartment, a possible pathway for Och1p retrieval in yeast ([@B22]). Future efforts will be directed at identifying the putative proteins whose retrieval to the *cis*-Golgi compartment is required for secretion in yeast.

Implications for the SNARE Hypothesis
-------------------------------------

In its original form, the SNARE hypothesis proposed that a specific set of v-SNAREs on transport vesicles and a specific set of t-SNAREs on target membranes serve as identifying markers. Their specific pairwise recognition would ensure that transport vesicles would fuse only with the correct target organelle ([@B63]; [@B17]; [@B54]). Recently an extension of the original SNARE hypothesis was made necessary by the discovery that Sed5p could interact not only with the v-SNAREs Sec22p/Sly2p, Bet1p/Sly12p, and Bos1p that are required for ER to early Golgi traffic but also with the v-SNARE Sft1p, which is involved in retrograde traffic from a later Golgi to the early-Golgi compartment ([@B2]). Vti1p-containing vesicles would represent a third kind of vesicle fusing with the early-Golgi compartment. This could mean that a t-SNARE defines a target organelle and can interact with v-SNAREs of all incoming vesicles to that organelle, instead of being restricted to a specific vesicle fusion event.

We demonstrate here by genetic and biochemical studies that a single v-SNARE can interact functionally with two different t-SNAREs in distinct compartments. A model to explain these data is that a v-SNARE functioning in anterograde trafficking to a target organelle also plays a critical role in docking and fusion of retrograde vesicles originating from the target organelle, while the v-SNARE itself is recycling. Alternatively, if Vti1p directs both anterograde and retrograde traffic from the late-Golgi compartment this could mean that a v-SNARE is present on different vesicle populations budding from a single donor compartment and may define the donor membranes. To interact specifically with either the anterograde or the retrograde t-SNARE, this v-SNARE must either be able to assume two different conformations, two modified states, or form complexes with additional proteins that modify the action of the v-SNARE. A protein able to fulfill the latter type of function has been identified in mammalian neurons. The v-SNARE synaptobrevin forms a complex with the synaptic vesicle protein synaptophysin, which excludes the t-SNARE syntaxin 1 ([@B14]), suggesting a role for synaptophysin in control of synaptobrevin activity. Therefore, it seems likely that the activity and possibly the specificity of v-SNAREs are regulated by interactions with additional proteins so that a single v-SNARE can direct vesicle fusion of two different classes of vesicles.
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Yeast Strains Used in this Study

  Strain        Genotype                                                                            Reference
  ---------- -- -------------------------------------------------------------------------------- -- -------------------------
  CTY10-5D      *MAT**a** leu2-3,112 his3-Δ200 trp1-Δ901 gal4 gal80 URA3::lexAop-LacZ*              ([@B4])
  SEY6210       *MAT*α *leu2-3,112 ura3-52 his3-Δ200 trp1-Δ901 lys2-801 suc2-Δ mel-*                (Robinson et al., 1988)
  SEY6211       *MAT**a** leu2-3,112 ura3-52 his3-Δ200 ade2-101 trp1-Δ901 suc2-Δ9 mel-*             (Robinson et al., 1988)
  SEY5186       *MAT*α *leu2-3,112 ura3-52 gal2 sec18-1*                                            (Emr et al., 1984)
  FvMY6         *MAT*α *leu2-3,112 ura3-52 ade2-101 trp1-Δ901 suc2-Δ9 mel- vti1::ΔHIS3*             This study
  FvMY7         *MAT**a** leu2-3,112 ura3-52 his3-Δ200 ade2-101 trp1-Δ901 suc2-Δ9 mel- vti1-1*      This study

###### 

Plasmids Used in this Study

  Plasmid      Description                                                                    Reference
  --------- -- --------------------------------------------------------------------------- -- -------------------------------------------------------------
  pSN206       *ADH1-LexA-VPS10*(tail) fusion in pEG202 (2μ-*HIS3*)                           This study
  p2H-1        5 kb genomic DNA with *VTI1* (codons 106-217) in pGAD3                         This study
  pSN258       *vti1Δ::HIS3* disruption construct in pRS305                                   This study
  pFvM7        *E. coli* expression vector pGex2T encoding GST-Vtilp (aal-194)                This study
  pFvM16       *GAL1-VTI1::HA* in pRS314 (*CEN6-TRP1*)                                        This study
  pFvM17       *GAL1-VTI1* in pRS314 (*CEN6-TRP1*)                                            This study
  pFvM20       *E. coli* expression vector pMal-p2 encoding MBP-Vtilp::HA (aal-194)           This study
  pFvM28       1.8 kb containing *VTI1* in pRS314 (*CEN6-TRP1*)                               This study
  pFvM29       1.8 kb containing *VTI1* in pRS316 (*CEN6-URA3*)                               This study
  pFvM32       1.8 kb containing *VTI1* in YEp352 (2μ-*URA3*)                                 This study
  pFvM38       *E. coli* expression vector pQE30 encoding 6His-Vtilp (aal-194)                This study
  pFvM40       *E. coli* expression vector pGEX2T encoding GST-Sed5p (aa1-324)                This study
  pFvM47       7.7 kb Chrom XII (nt190000-197700) containing *SED5* in YEp24 (2μ-*URA3*)      This study
  pFvM89       *SED5* in YEp351 (2μ-*LEU2*)                                                   This study
  pFvM92       *vti1-11* in pRS314 (*CEN6-TRP1*)                                              This study
  pFvM93       *vti1-2* in pRS314 (*CEN6-TRP1*)                                               This study
  pFvM103      *E. coli* expression vector pGex2T encoding GST-Sso2p (aal-269)                This study
  pFvM104      2.9 kb EcoRI-SnaBI DNA from pRB58 with *SUC2* in pRS316                        This study
  pRCP59       *E. coli* expression vector pGex3X encoding GST-Pep12p (aal-263)               R.C. Piper[\*](#TFII-150){ref-type="table-fn"}/T.H. Stevens
  pRCP110      *PEP12* in YEp351 (2μ-*LEU2*)                                                  R.C. Piper[\*](#TFII-150){ref-type="table-fn"}/T.H. Stevens
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![Amino acid sequence of yeast Vti1p. The predicted transmembrane domain is boxed. The predicted coiled coil domain is underlined (amino acids 159--188 with a *P* = 0.285 using the paircoil program \[[@B6]\]; amino acids 149--169 with a *P* = 0.58 using the coil program with a window of 21 \[[@B33]\]). These sequence data are available from GenBank under accession number AF006074.](JCB.14531f1){#F1}

![Vti1p localization. (*a*) Immunofluorescence microscopy of Vti1p. Anti-Vti1p antibodies reveal a punctate staining pattern distinct from the vacuoles seen by Nomarski optics. (*b*) Differential centrifugation of total yeast homogenate (*H*). Vti1p was predominantly found in the 200,000 *g* pellet (*P200*) with lower amounts in the 13,000 *g* pellet (*P13*). The syntaxin-related protein Pep12p had a similar distribution. (*c*) Sucrose density centrifugation of the S13 fraction. Vti1p migrated in two peaks, one cofractionating with the prevacuolar protein Pep12p and the other with the Golgi protein DPAP A. Fractions were collected from the top of the gradient (fraction *1*) and analyzed by SDS-PAGE and immunoblotting.](JCB.14531f2){#F2}

###### 

Depletion of Vti1p leads to growth arrest and CPY mislocalization. (*a*) Growth curves of the *GAL1--VTI1* and *GAL1-- VTI1-HA* strains in glucose-containing medium. Cells of both strains displayed equivalent growth properties and stopped dividing after 22 h. Cell density was measured by optical density at 600 nm. The cultures were diluted when they reached an optical density of about one to keep cells growing in logarithmic phase. Taking the dilution factor into account, the extrapolated cell densities were calculated from the measured optical densities. (*b*) CPY sorting in the *GAL1--VTI1-HA* strain grown in galactose and for different amounts of time in glucose medium. CPY sorting was followed by pulse--chase labeling and CPY immunoprecipitation from cellular extracts (*I*, intracellular) and medium (*E*, extracellular). For cells cultured in galactose, CPY reached the vacuole (presence of mCPY). After 16 h in glucose most of the CPY was secreted as the late Golgi precursor form, p2CPY. After longer time periods in glucose, the ER and early Golgi forms of CPY (*p1CPY*) accumulated within the cell.

![](JCB.14531f3a)

![](JCB.14531f3b)

![CPY sorting in *vti1-ts* mutants. CPY sorting was followed in the *vti1-1*, *vti1-2*, and *vti1-11* strains by pulse--chase labeling and CPY immunoprecipitations from cellular extracts (*I*, intracellular) and medium (*E*, extracellular). *vti1-1* cells were preincubated for 30 min at 36°C and *vti1-2* and *vti1-11* cells for 15 min. In the *vti1-1* and *vti1-2* cells most CPY was secreted or accumulated intracellularly as p2CPY at the restrictive temperature. In *vti1-11* cells, predominantly the ER or early Golgi form p1CPY accumulated intracellularly at the restrictive temperature.](JCB.14531f4){#F4}

![Invertase sorting in *vti1-ts* mutants. (*a--c*) Invertase immunoprecipitations from intracellular (*I*) and extracellular (*E*) fractions were performed directly after the pulse or after a 30-min chase. Wild-type (*WT*), *vti1*, and *sec18-1* cells were labeled at 22°C or after a 15-min preincubation at 36°C. Invertase was processed and secreted correctly in *vti1-2* strains at either temperature. In *vti1-1* cells, partially glycosylated invertase was secreted at 36°C. In *vti1-11* cells, the ER and early Golgi forms of invertase accumulated, and partially glycosylated invertase was secreted at 36°C. (*d*) Invertase was immunoprecipitated from the intracellular fraction of *vti1-11* and *sec18-1* cells, which were incubated at 36°C and chased for 30 min. Secondary immunoprecipitations were performed with antiserum against invertase (*Inv.*) or against α1, 6--linked mannose (1-6). *vti1-11* cells accumulated the ER form of invertase, which had not received α1,6--linked mannose, and the slightly larger *cis*-Golgi form, which could be precipitated with antiserum against α1,6--linked mannose.](JCB.14531f5){#F5}

![Electron microscopy of wild-type and *vti1* mutant cells. Cells were grown at 22°C and transferred to 37°C for 1 h. In *vti1-1* cells (*b*), small vesicles (*arrowheads*) accumulated. In *vti1-11* cells (*c*), small vesicles and ER membranes (*arrow*) accumulated. *N*, nucleus; *V*, vacuole. Bar, 500 nm.](JCB.14531f6){#F6}

![*SED5* overexpression suppresses *vti1Δ* lethality. Growth of the *GAL1--VTI1* strain alone or overexpressing Sed5p or Pep12p on plates containing galactose (*Gal*) or glucose (*Glc*). The *GAL1--VTI1* strain could not grow on glucose after the expression of *VTI1* was shut off. Overexpression of the early Golgi t-SNARE Sed5p allowed growth in the absence of Vti1p. Overexpression of the prevacuolar-localized t-SNARE Pep12p did not support growth of *vti1Δ* cells.](JCB.14531f7){#F7}

![CPY sorting in *vti1-1* (*a*) and *vti1-11* (*b*) cells overexpressing Sed5p and Pep12p. Overexpression of Pep12p in *vti1-1* cells partially restored CPY sorting to the vacuole at the restrictive temperature (36°C). Overexpression of Sed5p in *vti1-11* mutant cells reduced p1CPY accumulation at the restrictive temperature.](JCB.14531f8){#F8}

![Physical interaction of Vti1p with Sed5p and Pep12p. (*a*) Coimmunoprecipitation of Pep12p with Vti1p. Yeast spheroplasts were solubilized with 0.5% Triton X-100. Vti1p was quantitatively precipitated from the Triton extract by native immunoprecipitation with anti-Vti1p antibodies, and ∼10% of the total Pep12p was coimmunoprecipitated. In contrast, the membrane proteins Vph1p (vacuole) and Sac1p (ER and Golgi apparatus) were not coimmunoprecipitated, and pre-immune serum did not precipitate any of these proteins. For quantitative comparison, Triton extracts equivalent to 30 and 10% of total protein present in the immunoprecipitations were analyzed in lanes *3* and *4.* The proteins bound to the beads and the starting extracts were analyzed by SDS-PAGE and immunoblotting with antibodies against Vti1p, Pep12p, Vph1p, and Sac1p. (*b*) In vitro binding of the soluble domain of Vti1p to immobilized GST fusion proteins containing the soluble domains of different yeast t-SNAREs. Vti1p interacted with GST-Sed5p and GST-Pep12p but not with GST-Sso2p or GST alone. Equal amounts of immobilized GST fusion proteins were incubated with 6-His--Vti1p. The bound proteins were analyzed by SDS-PAGE and immunoblotting with anti-Vti1p antibodies.](JCB.14531f9){#F9}

![Model for Vti1p function in vesicle docking and fusion. Yeast Golgi- derived vesicles contain the v-SNARE Vti1p on the membrane allowing for its interaction with the t-SNARE Pep12p on the surface of the prevacuolar compartment (*PVC*). This interaction provides part of the specificity for fusion of Golgi-derived vesicles with the prevacuole. In addition, Vti1p interacts with the early Golgi t-SNARE Sed5p. We propose that Vti1p is involved in retrograde traffic from either the prevacuolar compartment or the late Golgi compartment back to the early Golgi compartment. Other v-SNAREs and t-SNAREs functioning in yeast ER, Golgi, and plasma membrane (*PM*) traffic are included. *E*, early Golgi; *M*, medial Golgi; *L*, late Golgi; *PVC*, prevacuolar compartment; *PM*, plasma membrane.](JCB.14531f10){#F10}
